| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $3.3M | — |
| SG&A Expense | $6.8M | +25.4% |
| Operating Income | -$4.2M | +65.4% |
| Pre-tax Income | -$5.6M | +42.4% |
| Income Tax | -$634K | -8025.0% |
| Net Income | -$4.9M | +49.0% |
| EPS (Basic) | -$0.79 | +83.4% |
| EPS (Diluted) | -$0.79 | +83.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $4.6M | -66.2% |
| Total Assets | $14.0M | -6.7% |
| Current Liabilities | $3.9M | +26.6% |
| Total Liabilities | $10.1M | +22.1% |
| Stockholders' Equity | $3.9M | -42.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | -194.0% |
| Capital Expenditures | $1K | — |
| Investing Cash Flow | -$1.8M | — |
| Financing Cash Flow | $1.6M | -88.1% |
| Free Cash Flow | -$8.6M | -194.0% |